Rocket Lab's stock has dropped from its 2026 highs despite a record $2.36 billion backlog and a transformative acquisition of Iridium, which adds recurring revenue and satellite assets. The company posted strong Q2 revenue growth of 62% and expects continued gains with the upcoming Neutron rocket launch and defense contracts. Analysts see potential for the stock to nearly double to $123.10 within 12 months, driven by backlog conversion and defense spending, though risks include execution delays and regulatory hurdles. The outlook favors investors willing to hold through volatility as Rocket Lab scales its launch and space systems business.
Rocket Lab is recognized for its strong execution in the aerospace sector, consistently beating analyst estimates for eight quarters. However, its stock trades at a high forward Price to Sales ratio of 40x, a significant premium over the sector media...
SpaceX shares rose 7% as investors anticipate the upcoming Starship test 14, the largest fully reusable rocket flight. Tesla also gained 7%, boosted by its ties to SpaceX and optimism around autonomy and manufacturing collaborations like the Terafab ...
AST SpaceMobile shares surged 12% following Berenberg's initiation with a $92 price target, highlighting its unique cellular broadband service from space. Planet Labs also rose 5%, supported by its daily Earth imaging and a growing backlog. The gains...
Rocket Lab is broadening its business beyond launch services to include manufacturing spacecraft components for commercial and government clients. Despite recent stock declines and competition, analysts from Berenberg Bank and Bank of America maintai...
Rocket Lab's stock has fallen over 57% from its peak despite strong revenue growth and a growing backlog, creating a disconnect between performance and market value. Analysts remain bullish, with a consensus price target implying about 77% upside and...
